Concepedia

Author

Maiko Hamada

Mitsubishi Tanabe Pharma Corporation

Also Known As

Maiko Hamada

8

Publications

92

Citations

5

H-Index

23

Concepts

All Affiliations

Mitsubishi Tanabe Pharma CorporationMitsubishi Chemical (Japan)
MH

About

Maiko Hamada is an author at Mitsubishi Tanabe Pharma Corporation specializing in immunology, drug discovery, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

73

2

Engineering

1

1

20

3

Natural Sciences

1

1

41

4

Biochemistry

1

1

41

5

Chemical Engineering

1

1

20

Maiko Hamada

×

3

Publications

73

Citations

3

H-Index

YearCitations

Removal of Sphingosine 1-Phosphate Receptor-3 (S1P<sub>3</sub>) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P<sub>1</sub> Agonists with Reduced Effect on Heart Rate

Maiko Hamada, Mitsuharu Nakamura, Masatoshi Kiuchi,

Journal of Medicinal Chemistry

2010

41

Efficient Synthesis of the Immunomodulating Compound KRP-203

Maiko Hamada, Masatoshi Kiuchi, Kunitomo Adachi

Synthesis

2007

20

A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor

Junichi Endo, Hidemasa Hikawa, Maiko Hamada,

Bioorganic & Medicinal Chemistry Letters

2016

12

Page 1